Prescription ID | TCMF2358 |
Pinyin Name | Yi Ren Chong Jiu Tang |
Chinese Name | |
English Name | YR Worm Alcohol Decoction |
Function Description | |
Indications | None |
Disease ICD-11 Category | |
Human Tissues Associated with Indication | |
Reference | Chinese Classical Prescriptions |
Reference Book/link | ISBN 7-5023-3930-2 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH2486 | Coix lacryma- jobi var. ma - yuen | 薏苡仁 | TCMH2486 | |
TCMH1964 | Eupolyphaga seu steleophaga | 庶虫 | TCMH1964 | |
TCMH562 | Saposhnikovia divaricata | 防风 | TCMH562 | ITSAE3225-14 |
TCMH1531 | Akebia quinata | 木通 | TCMH1531 | ITSAJ4440-14 |
TCMH524 | Eucommia ulmoides | 杜仲 | TCMH524 | ITSAM1588-14 |
TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH2073 | Prunus persica | 桃仁 | TCMH2073 | ITSAN1047-14 |
TCMH865 | Carthamus tinctorius | 红花 | TCMH865 | ITSAI2447-14 |
TCMH1695 | Pericarpium citri reticulatae viride | 青皮 | TCMH1695 | |
TCMH1768 | Panax notoginseng | 三七 | TCMH1768 | ITSAO2360-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT759 | SAE1 | SUMO-activating enzyme subunit 1 | Unclassified | Q9UBE0 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1174 | Mycobacterium bovis BCG |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1177 | Haemophilus influenzae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1184 | Mycobacterium fortuitum |
TCMT1185 | Mycobacterium phlei |
TCMT1187 | Enterococcus faecalis ATCC 29212 |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1191 | Bacillus megaterium |
TCMT1192 | Bacteria |
TCMT1193 | Staphylococcus |
TCMT1194 | Shigella sonnei |
TCMT1196 | Salmonella |
TCMT1198 | Serratia marcescens |
TCMT1199 | Streptococcus sp. 'group A' |
TCMT1200 | Bacillus thuringiensis |
TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
TCMT1202 | Mycoplasma hominis |
TCMT1203 | Mycoplasma pneumoniae |
TCMT1204 | Clostridium perfringens |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1216 | Vibrio cholerae |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1220 | Streptococcus pneumoniae R6 |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1243 | Aspergillus flavus |
TCMT1244 | Staphylococcus saprophyticus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1252 | Alcaligenes faecalis |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1262 | Mycoplasma putrefaciens |
TCMT1266 | Mycobacterium abscessus |
TCMT1267 | Mycobacterium chelonae |
TCMT1271 | Shigella flexneri |
TCMT1272 | Campylobacter jejuni |
TCMT1273 | Pseudomonas putida |
TCMT1274 | Shigella boydii |
TCMT1276 | Klebsiella |
TCMT1277 | Serratia |
TCMT1278 | Pseudomonas |
TCMT1281 | Clostridium difficile |
TCMT1282 | Colletotrichum orbiculare |
TCMT1286 | Bacillus cereus |
TCMT1287 | Bacillus subtilis subsp. spizizenii ATCC 6633 |
TCMT1289 | Shigella dysenteriae |
TCMT1290 | Acinetobacter calcoaceticus |
TCMT1291 | Haemophilus parainfluenzae |
TCMT1292 | Japanese encephalitis virus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1297 | Punta Toro virus |
TCMT1299 | Morganella morganii |
TCMT1300 | Enterobacter |
TCMT1301 | Klebsiella sp. |
TCMT1303 | Bacillus |
TCMT1304 | Staphylococcus capitis |
TCMT1305 | Salmonella enteritidis |
TCMT1307 | Penicillium marneffei |
TCMT1309 | Aspergillus clavatus |
TCMT1310 | Enterococcus hirae |
TCMT1314 | Streptococcus viridans |
TCMT1315 | Streptococcus sp. |
TCMT1317 | Staphylococcus lentus |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1322 | Streptococcus mitis |
TCMT1326 | Shigella |
TCMT1331 | Acinetobacter sp. |
TCMT1332 | Bacillus licheniformis |
TCMT1334 | Chlamydia trachomatis |
TCMT1336 | Yellow fever virus |
TCMT1337 | Dengue virus type 4 |
TCMT1338 | Rift Valley fever virus |
TCMT1340 | Staphylococcus faecalis |
TCMT1341 | Streptococcus oralis |
TCMT1342 | Streptococcus salivarius |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1345 | Prevotella loescheii |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1354 | Streptococcus mutans UA159 |
TCMT1355 | Rhodococcus equi |
TCMT1356 | Campylobacter coli |
TCMT1358 | Bacteroides vulgatus |
TCMT1361 | Neisseria meningitidis |
TCMT1362 | Bordetella pertussis |
TCMT1363 | Peptostreptococcus anaerobius |
TCMT1366 | Prevotella bivia |
TCMT1370 | Prevotella melaninogenica |
TCMT1371 | Veillonella parvula |
TCMT1375 | Clostridium tetani |
TCMT1377 | Staphylococcus lugdunensis |
TCMT1378 | Acinetobacter haemolyticus |
TCMT1381 | Listeria innocua |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1383 | Streptomyces griseus |
TCMT1388 | Prevotella disiens |
TCMT1389 | Klebsiella oxytoca |
TCMT1390 | Human herpesvirus 2 strain G |
TCMT1393 | Vibrio sp. |
TCMT1394 | Mycobacterium aurum |
TCMT1395 | Staphylococcus sp. |
TCMT1396 | Fusobacterium |
TCMT1399 | Chlamydophila pneumoniae |
TCMT1400 | Mycobacterium mageritense |
TCMT1401 | Staphylococcus warneri |
TCMT1402 | Staphylococcus cohnii |
TCMT1403 | Streptococcus constellatus |
TCMT1404 | Streptococcus intermedius |
TCMT1406 | Mycobacterium leprae |
TCMT1407 | Aeromonas punctata |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1409 | Escherichia coli O157:H7 |
TCMT1410 | Listeria monocytogenes |
TCMT1411 | Vibrio parahaemolyticus |
TCMT1412 | Salmonella typhimurium |
TCMT1413 | Vibrio splendidus |
TCMT1414 | Vibrio vulnificus |
TCMT1415 | Vibrio fluvialis |
TCMT1416 | Plesiomonas shigelloides |
TCMT1417 | Aeromonas sobria |
TCMT1418 | Enterobacteriaceae |
TCMT1420 | Klebsiella pneumoniae subsp. ozaenae |
TCMT1421 | Vibrio mimicus |
TCMT1422 | Clostridium histolyticum |
TCMT1423 | Peptostreptococcus |
TCMT1424 | Haemophilus ducreyi |
TCMT1425 | Moraxella bovis |
TCMT1427 | Proteus inconstans |
TCMT1429 | Acinetobacter pittii |
TCMT1431 | Coxiella burnetii |
TCMT1432 | Serratia sp. |
TCMT1434 | Plesiomonas |
TCMT1435 | Corynebacterium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 13.0591 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.0235 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, PIM1, PPARA, TYR, XDH | 11.7372 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 8.84554 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, HSD17B2, MET, PPARA | 7.94452 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH | 7.19558 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.95679 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH | 6.89854 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.82934 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.60545 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 6.30727 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC | 5.83282 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.78904 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA | 5.54474 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.37685 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR | 5.34281 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.34072 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 5.1857 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 5.1857 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, CA9, CYP1A1, CYP1A2, CYP1B1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR | 5.1857 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 5.17042 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, MET, PPARA | 5.14803 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD17B2 | 5.14353 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B2, TYR, XDH | 4.67214 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR | 4.53624 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, HCAR2, HSD17B2, KDR, MET, PPARA, SRC, TNKS, TNKS2, XDH | 4.21266 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, FUT7, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR | 4.19288 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR | 3.98508 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA | 3.8143 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH | 3.80386 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.63089 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.63089 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC | 3.63089 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR | 3.36789 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TYR | 3.24222 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC | 3.1975 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH | 3.16653 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.15846 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FLT3, RORC, SRC, TYR | 3.15846 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH | 3.13661 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH | 3.13661 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, CA2, CA7, HCAR2, KDR, SRC, TNKS, TNKS2 | 2.97423 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC | 2.92012 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC | 2.89241 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TYR | 2.88602 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, CYP1B1, FLT3, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 2.88602 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 2.87876 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, XDH | 2.87751 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 2.84523 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, TYR | 2.83232 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, CYP1B1, FLT3, KDR, MET, PTPN1, SRC, XDH | 2.78808 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.77042 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, CA2, CA9, CYP1A2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC | 2.76821 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS | 2.76603 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B2 | 2.65825 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.65032 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B2 | 2.63969 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, MMP9, SRC | 2.63969 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.6266 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, TYR | 2.57973 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, APP, CDC25B, CYP1B1, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH | 2.57973 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.57151 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.56782 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC | 2.56782 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, FLT3, IGF1R, KDR, PIM1, SRC | 2.56684 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC | 2.5656 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 2.54886 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, MET, MMP9, PPARA, SRC | 2.47207 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 2.47207 |
[BP] GO:0010038 | response to metal ion | ALOX15, APP, CA2, CYP1A1, CYP1A2, FABP4, MMP9 | 2.40372 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.39904 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AXL, CYP1B1, FABP4, FLT3, KDR, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 2.37811 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, CYP1B1, FLT3, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, XDH | 2.36806 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.36392 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR | 2.35333 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH | 2.34702 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, CDC25B, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS | 2.32916 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH | 2.32916 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.32672 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC | 2.30053 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, HCAR2, TNKS, TNKS2 | 2.29263 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, MET, MMP9, PPARA, SRC, TNKS | 2.26187 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.25438 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, CYP1A1, CYP1B1, FLT3, RORC, SRC | 2.21283 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B2 | 2.21283 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.21283 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 | 2.18651 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CYP1B1, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH | 2.16068 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH | 2.1601 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, TYR | 2.14716 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.14716 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.14716 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.14716 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 | 2.14705 |
[BP] GO:1904353 | regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.13894 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA6, CA9, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TYR | 2.1368 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC | 2.1368 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, CA2, CA9, CYP1A2, FABP3, FLT3, PPARA, SRC | 2.1259 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B2 | 2.11281 |
[BP] GO:1904357 | None | SRC, TNKS, TNKS2 | 2.10763 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, FLT3, KDR, PTPN1, SRC, XDH | 2.10763 |
[BP] GO:0032204 | None | AURKB, SRC, TNKS, TNKS2 | 2.08063 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 2.06723 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC | 2.02134 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6 | 2.02095 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, SRC | 2.01457 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH | 2.00302 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 1.85617 |
[CC] GO:0005641 | nuclear envelope lumen | ALOX5, APP | 1.65712 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, FUT7, HCAR2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR | 1.5525 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, FUT7, HSD17B2, KDR, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH | 1.46786 |
[CC] GO:0097386 | None | AKR1B1, APP | 1.14354 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 18.4753 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH | 17.8448 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.1216 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH | 11.6868 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.9866 |
[MF] GO:0043167 | ion binding | ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH | 9.10733 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TYR, XDH | 7.35231 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 7.22525 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 7.14964 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TYR, XDH | 6.94232 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS | 6.89854 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH | 6.56615 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B2, TYR, XDH | 5.62335 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 5.60573 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 5.45468 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC | 4.67916 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC | 4.48581 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 4.26638 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 4.17911 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.63089 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6 | 3.17749 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.16653 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.73118 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.70708 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC | 2.36392 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, CBR1, HSD17B2, XDH | 2.2698 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, XDH | 2.21523 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 20.1252 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 6.8539 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 6.019 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 5.838 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, TYR, CYP19A1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH | 4.702 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 5.2305 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, IGF1R | 3.8784 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 4.3593 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SRC, MET, IGF1R | 3.4685 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.5473 |
Pathways in cancer_Homo sapiens_hsa05200 | FLT3, MMP1, MMP2, MMP9, MET, IGF1R | 2.4337 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 2.9161 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15 | 2.4167 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIM1, CYP1B1, MMP9, MET, CDC25B | 2.2421 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1 | 2.3865 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, MET, IGF1R | 2.0404 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 2.1766 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KDR, MET, IGF1R | 2.0033 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9 | 2.0033 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.5038 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, ALOX15 | 1.9087 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.8035 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, ADORA1, PPARA | 1.4041 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 1.2802 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.4958 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.4957 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.467 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.4041 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.4811 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, PIM1 | 1.1717 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.4041 |
Melanoma_Homo sapiens_hsa05218 | MET, IGF1R | 1.4041 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 1.1486 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.2348 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 1.1856 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2 | 1.4041 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, XDH | 1.6463 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.3383 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 1.1309 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | KDR, MET, IGF1R | 0.9326 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.0502 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.9263 |
Hepatitis B_Homo sapiens_hsa05161 | SRC, MMP9 | 0.9389 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.9363 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 1.0832 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 1.0871 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.871 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.8228 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.9069 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | ADORA3, ADORA1 | 0.5935 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.5415 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.5935 |
Glioma_Homo sapiens_hsa05214 | IGF1R | 0.5935 |
Prostate cancer_Homo sapiens_hsa05215 | IGF1R | 0.5415 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5935 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.5415 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.5378 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC | 0.5352 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.5141 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC | 0.5787 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE | 0.5141 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.5345 |
Gap junction_Homo sapiens_hsa04540 | SRC | 0.5415 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.5415 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5743 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.5022 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5935 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.5415 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.3242 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5345 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | IGF1R | 0.5322 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.5415 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC | 0.5022 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC | 0.3764 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.5022 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5378 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.3866 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5415 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5787 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1 | 0.4552 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.4626 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5 | 0.5022 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5935 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.4262 |
AMPK signaling pathway_Homo sapiens_hsa04152 | IGF1R | 0.5022 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.4905 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.5378 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.4835 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.5935 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | IGF1R | 0.4802 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.4552 |
Tight junction_Homo sapiens_hsa04530 | SRC | 0.4835 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.4905 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.4262 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.4378 |
Cell cycle_Homo sapiens_hsa04110 | CDC25B | 0.5022 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.4134 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4981 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.5787 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5935 |
Malaria_Homo sapiens_hsa05144 | MET | 0.656 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.787 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8297 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.871 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.8351 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.871 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 1.0871 |